Two viruses cause most liver cancer worldwide. One is preventable by vaccine, the other curable with pills, which makes liver cancer one of the most preventable cancers.
HBV (integration and chronic inflammation) and HCV (chronic inflammation, cirrhosis) account for the majority of HCC globally. Universal HBV vaccination in Taiwan cut childhood HCC incidence by ~70%; direct-acting antivirals cure HCV in >95% and reduce HCC risk by roughly 70%, though risk persists in established cirrhosis. MASLD is now the fastest-growing cause in Western countries.
Showing the technology this term belongs to: HPV & HBV vaccination.
Shares HPV & HBV vaccination, Prevention we already have is not deployed, Most of the world has almost no cancer care, Hepatocellular carcinoma.
Shares Early hepatocellular carcinoma (BCLC 0 and A), Advanced hepatocellular carcinoma (BCLC C), Hepatocellular carcinoma.
Shares Caution: bevacizumab-based regimens with untreated varices, Advanced hepatocellular carcinoma (BCLC C), Hepatocellular carcinoma.
Shares HCC surveillance in cirrhosis (ultrasound + AFP), Early hepatocellular carcinoma (BCLC 0 and A), Hepatocellular carcinoma.
Shares Prevention we already have is not deployed, Most of the world has almost no cancer care, Hepatocellular carcinoma.
Shares Early hepatocellular carcinoma (BCLC 0 and A), Advanced hepatocellular carcinoma (BCLC C).
Shares HPV & HBV vaccination, Prevention we already have is not deployed, Most of the world has almost no cancer care.
Shares Early hepatocellular carcinoma (BCLC 0 and A), Hepatocellular carcinoma.